Pharma Journalist 9038 posts 0 comments

Bio-Thera Solutions, Ltd. and BeiGene, Ltd. announced that the companies have executed a license, distribution, and supply agreement for China for Bio-Thera’s BAT1706, an…
Read More...

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce targeted polyclonal antibodies, announced the dosing of the…
Read More...

SMi reports: Alan Franklin, CEO, ForwardVue Pharma will be presenting at the Ophthalmic Drugs conference The 4th Annual Ophthalmic Drugs Conference taking place on the 23rd -24th…
Read More...

 Renalytix AI plc announced a collaboration with AstraZeneca to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases. The first stage in the…
Read More...

SMi reports: Insightful content from expert speakers Shannon Clark, UserWise and Steven Badelt, Suttons Creek, Inc. SMi are delighted to have Shannon Clark, Principal, UserWise and…
Read More...

Sanofi and Principia Biopharma Inc. entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100  per share in cash, which…
Read More...

Boehringer Ingelheim announced that the first patient has enrolled in InPedILD, a global Phase III trial assessing the dosing and safety profile of nintedanib in children and…
Read More...

QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with…
Read More...

Celleron Therapeutics, the UK-based company developing novel medicines for cancer patients, announced the signing of a licensing agreement with Roche providing Celleron exclusive…
Read More...

GeneCentric Therapeutics announced it has entered into a research collaboration with Janssen Research & Development, LLC (Janssen) around RNA-based drug response biomarkers for…
Read More...